 | |
| Clinical data | |
|---|---|
| Drug class | Serotonin–norepinephrine–dopamine reuptake inhibitor |
| Identifiers | |
| |
| CAS Number |
|
| PubChemCID | |
| ChemSpider | |
| UNII | |
| ChEMBL | |
| Chemical and physical data | |
| Formula | C16H16F2N2 |
| Molar mass | 274.315 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
Lafadofensine (INNTooltip International Nonproprietary Name), also known as(3S)-N,N-bis(4-fluorophenyl)pyrrolidin-3-amine, is adrug described as anantidepressant which has not been marketed at this time.[1][2][3] It is said to act as aserotonin–norepinephrine–dopamine reuptake inhibitor (SNDRI).[1] The drug was first described by 2010[4] and itsINNTooltip International Nonproprietary Name was proposed by 2021.[5]
-fensine norepinephrine, serotonin, dopamine reuptake inhibitors brasofensine (76), diclofensine (44), lafadofensine (126), liafensine (109), nomifensine (24), perafensine (44), tesofensine (89)
 | Thispsychoactive drug-related article is astub. You can help Wikipedia byexpanding it. |